Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-274329
Filing Date
2024-12-10
Accepted
2024-12-10 16:02:26
Documents
4
Period of Report
2025-01-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A d852912ddef14a.htm DEF 14A 228281
2 GRAPHIC g852912dsp026.jpg GRAPHIC 126643
3 GRAPHIC g852912dsp027.jpg GRAPHIC 124486
4 GRAPHIC g852912g53p02.jpg GRAPHIC 35870
  Complete submission text file 0001193125-24-274329.txt   615360
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

EIN.: 833197402 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39244 | Film No.: 241538429
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)